Search for Clinical Trial Results

Sponsored By

Neoplasms, Cystic, Mucinous, and Serous - 7 Studies Found

Status Study
Completed Study Name: Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms
Condition: Neoplasms, Cystic, Mucinous, and Serous
Date: 2013-09-30
Interventions:
  • Drug: Ethanol EUS-guided lavag
Withdrawn Study Name: Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms
Condition:
  • Neoplasms, Cystic, Mucinous, and Serous
  • Pancreatic Neoplasms Date: 2010-01-26
    Interventions: Procedure: EUS and/or ERCP with ethanol injections of pancreatic cyst Lavage of cyst with 80% ethanol
Completed Study Name: Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor
Condition:
  • Pancreatic Tumor
  • Endocrine Tumor
  • Neo
    Date: 2014-12-20
    Interventions: Procedure: Radiofrequency Ablation under EUS Pancreatic radiofrequency ablation under endoscopic ultraso
Active, not recruiting Study Name: Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Condition:
  • Adenocarcinoma
  • Rectal Diseases
  • Colorectal Neoplasms
    • <
    Date: 2013-11-21
Active, not recruiting Study Name: Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Condition:
  • Adenocarcinoma of the Rectum
  • Adenocarcinoma
  • Adenocarcinoma
    Date: 2009-12-18
    Interventions: Other: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
Completed Study Name: Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Adenocarcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Drug: Brivanib Alaninate Given